Xenetic Biosciences XBIO
NASDAQ XBIO
$2.32 +0.06 (+2.65%)
At close: Sep 30, 2026 · 4:00 PM EDT

Xenetic Biosciences (XBIO) Deferred Taxes (2020)

Updated

Xenetic Biosciences (XBIO) posted Deferred Taxes of $5.84 million for Q4 2020.

Analysis

Xenetic Biosciences (XBIO) Deferred Taxes (2020) Analysis & Trends

For FY2020, Xenetic Biosciences' Deferred Taxes came in at $2.92 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Deferred Taxes (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -479.00 Mn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -195.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -544.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -398.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -291.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -587.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -1.32 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Xenetic Biosciences 5.44 Mn -20.39 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 5.84 Mn
API Access

Xenetic Biosciences Deferred Taxes API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=deferred-taxes&ticker=XBIO&period=max&api_key=YOUR_API_KEY